Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by dardanion Jul 17, 2016 10:59am
94 Views
Post# 25059698

RE:RE:I was wrong....

RE:RE:I was wrong....
By the way skier59, you should quit trying to make false comments and then attribute them to me. I don't say the science won't work only that I am skeptical and with good cause. Do a Google search on TLT if you dare and you'll see endless YouTube videos pop up featuring Roger giving investors a lecture of what the company's strategic goals will be in the coming months of when the video was shot. I say if you dare because it soon becomes glaringly obvious that Roger has not done a very good job of meeting his stated timelines for both the TLC division and the PDT. But that's another subject in itself. Point being, information on what TLT hopes to achieve have been out there in abundance for years. Experts in the scientific community, high profile money managers and senior executives of highly competitive big pharma companies all who are a lot smarter than me know about or should by now be familiar with TLT's pre-clinical research so why no talk of a stink bid takeover when the stock is dirt cheap or at the very least a strategic partnership? From what I can see there is no buzz surrounding the company unless you consider buzz as being the hope of a relatively speaking good payday of a few cents for day traders on the back of an ITA announcement? Will you be there to sell skier59? What a dumb question....eh?
Bullboard Posts